Positively Sharing

Sales of AstraZeneca’s Covid vaccine slow to zero

Reading Time: < 1 minute

AstraZeneca made no money from its Covid-19 vaccine in the second quarter of the year for the first time since it developed the drug which helped protect people from the pandemic. Read More

Exit mobile version